# FDA recall D-832-2013

> **Sandoz Incorporated** · Class I · drug recall initiated 2013-05-20.

## Product

Methotrexate Injection, USP, Preservative-Free, 1 g/40 mL (25 mg/mL), 40 mL Single Dose Vial, Rx only, Manufactured for: Sandoz Inc., Princeton, NJ  08540; Manufactured by: EBEWE Pharma Ges.m.b.H. Nfg.KG, A-4866 Unterach, AUSTRIA, NDC 66758-041-01.

## Reason for recall

Presence of Particulate Matter: Found during examination of  retention samples.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-832-2013
- **Recalling firm:** Sandoz Incorporated
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-05-20
- **Report date:** 2013-08-14
- **Termination date:** 2014-01-29

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Broomfield, CO, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-832-2013

## Citation

> AI Analytics. FDA recall D-832-2013. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-832-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*